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Six commercially available infant formulas (IF) without added prebiotic, were investigated as substrates 
for the growth of bifidobacteria isolated from the feces of 3 day old babies. This investigation tracked, 
during 48 h, the microbiological and biochemical changes in prepared infant formula meals, caused by 
the action of bifidobacteria, isolated from babies’ feces. Pancreatin digestion preceded inoculation of 
the bifidobacteria biomass. The reference substrate was mature breast milk. This investigation showed 
important differences in bifidogenic effect between individual infant formulas and mature breast milk. In 
relation to dry biomass from the mature breast milk, dry biomass obtained in individual infant formulas 
ranged from 71.4% (IF-1) to 34.6% (IF-6). The results showed that, with the similar declared nutritive and 
biological characteristics, there are important differences between individual infant formulas. The 
results obtained showed that, an  in vitro bifidogenic index test which covers tracking of 
microbiological and biochemical changes should be developed as a usefull tool in determining the 
suitability of infant formulas and it should be one of the first steps before clinical investigations. 
 
Key words: Infant formula, bifidobacteria, prebiotics, bifidogenic effect.  
 
 
INTRODUCTION 
 
At birth, the sterile infant’s gut becomes inoculated with 
bacteria from the mother and from the environment. 
Within a few days, the type of milk feeding becomes one 
of the most important factors for the further development 
of the intestinal microbiota (Satokari et al., 2002). Many 
studies have shown differences in the fecal microbiota 
between breast-fed and formula-fed infants. In general, 
the microbiota of breast-fed infants mainly contains 
bifidobacteria, while the microbiota of formula-fed infants 
is more diverse, with bifidobacteria often being the 
predominant  species,  but   also   containing   substantial  
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quantities of Bacteroides, Enterobacteriaceae and 
Clostridium species (Harmsen et al., 2000; Leahy et al., 
2005; Penders et al., 2006; Solis et al., 2010).  
Human breast milk is the best food for a newborn baby 
(Pronczuk et al., 2004; WHO, 1981). In addition, it 
protects against infections (Pettigrew et al., 2003) and 
atopy (Gdalevich et al., 2001). Mothers who are not able 
to nurse their babies, often for different reasons, feed 
them with infant formulas “substitutes for breast milk” 
(Hamosh, 1999; The Commission of the European 
Communities, 2006). The complex composition of breast 
milk is impossible to fully attain in infant formulas, 
especially that related to the biologically active compo-
nents (immunoprotective and other non-immunogenous 
protective substances, growth factors, hormones and 
enzymes) (Alles et al., 2004; Agostoni and Domellof, 
2005). In addition, breast milk contains over one hundred 
different oligosaccharide structures that together with the 
other milk components, are the major source of prebiotic 
effect (Guidel-Urbano and Goni, 2001; Euler et al., 2005). 
Non-digestible oligosaccharides in  human  milk  contri- 
  
 
 
 
bute to the bifidogenic microbiota of breast-fed infants. 
These oligosaccharides are prebiotics, they are not 
digested by human gastrointestinal enzymes, but enter 
the colon intact, where they serve as fermentable substrates 
for the colonic microbiota (Gibson and Roberfroid, 1995), 
preferably bifidobacteria (Roberfroid, 2000). 
The bifidogenic effect (Gibson and Roberfroid, 1995) is 
the growth stimulation of bifidogenic bacteria, which are 
probiotics, in the intestinal tract by the effect of food 
ingredients, prebiotics for these bacteria. (Schrezenmeir 
and De Vrese, 2001; Simmering and Blaut, 2001; WHO, 
2003; Manning and Gibson, 2004). The bifidogenic effect 
is in addition to its usual properties of nutritive and biological 
value, one of the most important biological indicators of 
the resemblance of infant formulas to breast milk. For this 
reason, it is necessary to know and also control this 
property. 
Manufacturers are trying to produce infant formula that 
closely resembles the mothers’ breast milk. Although, the 
composition of all infant formulas, without added prebiotics, 
is relatively similar, it can be assumed that, despite that, 
there are still differences in their effect on the 
development of the intestinal flora of the babies, primarily 
on the growth of bifidobacteria. Therefore, this study 
measured differences in microbiological and biochemical 
parameters resulting from the growth of bifidobacteria in 
different infant formulas, in comparison to their growth in 
mature breast milk. 
 
 
MATERIALS AND METHODS 
 
Chemicals 
 
All chemicals were of analytical grade and purchased from Merck 
(Darmstadt, Germany), Sigma (Stenheim, Germany) and Torlak 
(Belgrade, Serbia). 
 
 
Substrates 
 
Six commercially available infant formulas, without added prebiotic, 
(designations IF-1 to IF-6) were prepared according to the 
instructions of their producers. All infant formulas were based on 
cow’s milk. It was included only the “starting milks” or “first milks”; 
formulated to meet the needs of healthy full-term infants, from 0 to 
4 months of age. Table 1 indicates the general composition of each 
formula described in the information provided on each packet.  
Bifidobacteria medium with lactulose (BML) broth (Nebra and 
Blanch, 1999) was a control substrate. Mature breast milk (MBM) 
was the reference substrate and it comprised of equal volumes of 
20 breast milks obtained from 20 healthy mothers who had 
delivered full-term infants (samples being obtained from 3 to 10 
days postpartum). Milk samples were collected in the Clinic for 
gynecology and obstetrics, University Clinical Centre, Belgrade, 
Serbia. All breast milk samples were frozen and stored at -20°C 
until analysis. 
 
 
Material for the isolation of bifidobacteria and preparation of 
inoculum  
 
Material  for  the  isolation  of  the  accumulated   mixed   culture   of  
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Bifidobacterium spp. was 1 g mixture of the 30 feces of healthy, 
vaginally and interm born babies, who were exclusively nursed and 
did not consume antibiotics. The feces were sampled three days 
after birth, directly upon excretion. All samples were frozen and 
stored at -20°C until preparation of the inoculum. 
Bifidobacteria were isolated on a solid BML. The inoculum was 
prepared from the third 48 h subculture on a BML agar slant, into 
10 ml liquid BML which was then incubated for 48 h at 37°C in an 
anaerostat (produced by "Heraeus") under an atmosphere of 
carbon dioxide (CO2). The total volume required was prepared by 
mixing several individual inoculums in order to obtain a large 
enough biomass for all the required seeding.  
 
 
Identification of the in vitro bifidobacterial isolates  
 
Isolated colonies growing on BML were identified as members of 
the genus Bifidobacterium using rapid kits (RAPID ID 32A®; 
bioMerieux, Marcy-l’Etoile, France). These test kits are based on 
evaluation of a range of enzymes and allow classification to the 
genus level within 4 h. 
 
 
Pancreatic digestion – digestion simulation (Despopoulos and 
Silbernagl, 2003)  
 
Digestion was carried out in wide-necked Erlenmayer flasks of total 
volume 300 ml.  Substrates (100 ml volumes) were added indivi-
dually to Erlenmayer flasks, together with 50,000 USNF units 
(General Committee of Revision, 1989) of amylase and protease 
and 4,000 USNF units of  lipase (pancreatin powder; A. 
Constantino & Co., Italy).  
Pancreatic digestion was performed by immersion in a water bath 
at 37°C for 2 h, with occasional shaking. Digestion was halted by 
sterilization (121°C for 20 min), allowing thermal deactivation of the 
enzymes. For one series of experiments, two Erlenmayer flasks 
with the same substrates were prepared, one of which was used 
after inoculation for the determination of the parameters at the 
beginning of the experiment. 
 
 
In vitro bifidogenesis 
 
Sterile “digested” substrates were inoculated with 1.0 ml of 
inoculum from the same accumulated mixed culture of 
bifidobacteria. Bifidogenesis lasted for 48 h at 37°C in anaerostat 
with CO2.  
 
 
Microbiological and analytical methods 
 
Description of a native microscopic preparation (Gojgic-
Cvijovic and Vrvic, 2003) 
 
A native preparation was obtained from the substrate and observed 
with a light microscope operating in the bright field ("Laboval", 
Zeiss, Germany) and observed using bright field microscopy. 
 
 
Determination of the total number of bifidobacteria (TNB) 
(Collins et al., 2004) 
 
Suitable dilutions of substrates and pure cultures of bifidobacteria 
were prepared in physiological saline and spread-plated onto BML 
agar. BML agar plates were incubated for 48 h at 37°C in a CO2 
atmosphere and plates with isolated bifidobacteria colonies counted 
to obtain TNB (expressed in colony-forming units per ml (cfu/ml)). 
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Table 1. Composition of infant milk-based formulas according to the information provided on labels. 
 
Formula Lipida Proteina Carbohydratea Main ingredientsb 
IF 1 23.1 12.8 58.3 Skimmed milk, lactose, starch, palm olein, demineralized whey milk, 
colza, coconut and sunflower oils, soybean lecithin 
IF 2 24.0 12.5 58.6 Demineralized whey milk, skimmed milk, palm olein, lactose, colza, 
palm and corn oils, soybean lecithin 
IF 3 24.4 11.7 58.6 Demineralized whey milk, milk powder (partially demineralized), 
vegetable oils (palm, colza, sunflower), lactose   
IF 4 26.0 9.5 58.0 Skimmed milk, vegetable oils (palm, coconut, sunflower, soybean), LC-
PUFA (arachidonic and docosahexaenoic acid), lactose, milk proteins, 
soybean lecithin 
IF 5 25.9 10.9 58.3 Skimmed milk, demineralized whey powder, vegetable oils, corn 
starch, LCP oils (vegetable, fish) 
IF 6 26.0 10.7 58.3 Lactose, vegetable oil, skimmed milk, corn starch, serum proteins, egg 
phospholipids 
 
aExpressed as g/100g of powder; b Ingredients are listed in the order in which they appear on the label. Beside this main ingredients, all 
infant formulas had also micronutrients (mineral components, vitamins and other microcomponents such as taurine). 
 
 
 
Determination of the dry biomass (DBM) (Gojgic-Cvijovic and 
Vrvic, 2003) 
 
The dry biomass was determined gravimetrically from 10 ml culture-
inoculated substrate, by centrifugation at 4,500 rpm for 10 min, 
triple water rinsing and measured using a hygrometer type 
“Shimazu”-moisture balance MOC-120H. The results are expressed 
in g/100 ml. 
 
 
Determination of pH  
 
The pH was measured using a pH-meter type PHM 26, with a 
combined glass electrode type GK 2401C (“Radiometer”). 
 
 
Determination of the total organic acids (TOA)  
 
Total organic acids were determined by automatic potentiometric 
titration (Titrator type TT 2, “Tacussel”, France, combined glass 
electrode type GK 2401C, “Radiometer“) of 50 ml samples with a 
standard 0.1 M NaOH solution. The results were calculated as lactic 
acid and are expressed in g/100 ml. 
 
 
Determination of the mole ratio of acetic and lactic acid 
(MRAL)  
 
The molar ratio of acetic and lactic acid was determined by 
enzymatic tests in accordance with the producer’s instructions 
(«RANDOX», Crumlin, UK) (Manual Acetic and Lactic acid, 1999), 
modified for these substrates (Filtration through a 0.2 µm pore size 
membrane and without alkaline hydrolysis). 
 
 
Statistical analysis 
 
All statistical analysis of microbial counts, microbiological and 
biochemical parameters were calculated by statistical program 
SPSS, version 11.5. One-way ANOVA test was used to compare 
the observed parameters of all eight substrates, while for intergroup 
comparisons, the Bonferroni test was used. Values of p < 0.05 were 
considered significant. Five replicates of each of the eight 
substrates were prepared and the parameters for each replicate 
(Microscopy, TNB, DBM, pH, TOA and MRAL) were measured 
individually. Microscopy, TNB, DBM, pH and TOA were measured 
at the start and end of the study, while MRAL was measured only at 
the end after bifidogenesis.  
 
 
RESULTS  
 
An in vitro artificial model as simulation of gastrointestinal 
transit was used to study bifidogenic effect of six 
commercial infant formulas, without adding prebiotic (IF1 
and IF6). This model consisted of incubation chambers 
(Erlenmeyer flask), each containing an infant formula (IF1 
and IF6) and also comparable chambers containing 
mature breast milk (MBM) and selective medium with 
lactulose broth (BML). All substrates were mixed with 
digestive enzymes using incubation techniques for 
solubilisation of nutrients and were subsequently 
inoculated and incubated with bifidobacteria. 
At the beginning and end of the investigation, the 
microbiological (description of the native microscopic 
preparation, the total number of bifidobacteria and their 
dry biomass) and biochemical indicators (pH, total 
bacterial generated organic acids and at the end of the 
experiment mole ratio of the obtained acetic and lactic 
acids) were determined. These indicators were a 
reflection of the changes of the substrates caused 
exclusively by the action of bifidobacteria and the 
stimulation of their multiplication under the effects of 
infant formula as prebiotics.  
Before addition of inoculums, the measured pH was 
lowest in MBM 6.55, while other samples had relatively 
similar initial pH in a range from 6.65 IF-5, over 6.70 IF-6, 
6.73 IF-3, 6.78 IF-1 and highest pH was measured in 
samples IF-2 6.82 and IF-4 6.89, which was close to the 
initial pH of the control substrate (BML) 6.80. 
The mole ratio of the produced acetic and lactic acids 
(3:2)  is  a  characteristic  of  the   genus   Bifidobacterium  
  
 
 
 
Table 2. Microbiological indicators of the bifidogenic effect at the 
end of the experiment (given as mean ± SD). 
 
Substrate TNBx107(cfu/ml) DBM (g/100 ml) 
IF 1 1.34 ± 0.164 0.227 ± 0.009 
IF 2 1.60 ± 0.265 0.162 ± 0.010 
IF 3 1.02 ± 0.053 0.164 ± 0.008 
IF 4 1.08 ± 0.278 0.143 ± 0.011 
IF 5 2.00 ± 0.583 0.113 ± 0.004 
IF 6 0.55 ± 0.374 0.109 ± 0.004 
BML 0.30 ± 0.035 0.095 ± 0.001 
MBM 0.80 ± 0.132 0.318 ± 0.006 
 
IF, Infant formula; BML, bifidobacteria medium with lactulose; MBM, 
mature breast milk; TNB, total number of bifidobacteria; DBM- dry 
biomass. 
 
 
 
(without generation of CO2) (De Vries and Stouthamer, 
1968), which was, besides the RAPID ID 32A® identifi-
cation system for anaerobes, used as an additional 
indicator that the changes really were the consequence 
of the bifidogenic effect of the substrate. The microbio-
logical indicators at the end of the experiment are given 
in Table 2.  
The values at the beginning of the study were identical, 
with that in the native preparation, the bacterial cells were 
extremely small, of irregular characteristically elongated 
shape, in all substrates the TNB was 6.14 x 105 cfu/ml 
and dry biomass 0.005 g/100 ml. 
The total number of bifidobacteria for all substrates at 
the end of the experiment was practically the same (107 
cfu/ml). Also, there was no statistically significant 
difference in TNB between infant formulas and reference 
substrate (Table 2). There was no direct correlation 
between the total number and the dry biomass of the 
bifidobacteria, which is a clear consequence of their 
ability to undergo polymorphism. As expected, the most 
suitable substrate for the production of biomass was 
mature breast milk. However, important differences in the 
dry biomass were found between the different infant 
formulas. For that reason, the bifidogenic index (BI) was 
calculated. The BI (developed in the current study) is the 
ratio of bifidobacteria dry biomass obtained in the same 
series of the experiment at the end of the test with infant 
formula, breast milk multiplied by hundred, that is 
expressed in percentages, as a discriminatory criterion 
for the estimation of the bifidogenic effects. The values 
obtained in this study are shown in Figure 1. 
In the current study, the BIs obtained from commercial 
infant formulas were significantly different (p < 0.05) to 
the BI of MBM. In relation to the dry biomass from mature 
breast milk, the dry biomass obtained in the individual 
infant formulas was within the limits from 71.4 (IF-1) to 
34.6% (IF-6). Changes in the biochemical indicators are 
given in Table 3.  
The bacterially generated TOA at the beginning of the 
experiment were 0.015 g/100 ml in all  substrates.  At  the  
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               Substrate 
 
 
Figure 1. Estimation of the bifidogenic effects. 
Bifidogenic index (BI). IF, Infant formula; BML, 
bifidobacteria medium with lactulose; MBM, mature 
breast milk. 
 
 
 
end of the process, as the result of the in vitro bifido-
genesis, the pH in all substrates was 3.5  and 3.6 
(Between 3.47 for IF-5 and 3.62 for IF- 4, with a mean 
value of 3.55), which corresponds to lactic buffer with a 
high buffer capacity, since the pH is approximately the 
pKa of lactic acid (pKa = 3.86) (Lurie, 1978). The concen-
tration of the bacterially generated total organic acids in 
all infant formulas was higher in relation to the reference 
substrate and the differences in relation to mature breast 
milk were from 5.8 (IF-2 and IF-3) to 21.4% (IF-6). 
Although, bacterially generated TOA increased noticeably 
in all samples, the difference between the samples and 
the reference substrate (MBM) was not statistically 
significant (p > 0.05). 
The mole ratio of acetic and lactic acids in all the 
investigated substrates was very close to 3:2, which is a 
physiological-biochemical characteristic of the genus 
Bifidobacterium. This result is an additional confirmation 
that, the isolated accumulated mixed culture consists only 
of bifidobacteria species and that the changes of the 
substrate were only the consequence of bacterial action, 
that is, the result of bifidogenesis. 
 
 
DISCUSSION 
 
Since all the replicates were performed simultaneously 
with the same inoculum and mature breast milk, possible 
mistakes were avoided due to the absence of standard 
mature breast milk and standard inoculum. In order to 
obtain an “average” inoculum and breast milk substrate, 
all replicates were prepared with inoculum, which was 
obtained from 1 g  of  feces,  which  was  comprised  of  a  
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Table 3. Changes in the biochemical indicators (given as mean ± SD). 
 
Substrate pH0 pH48 TOA (g/100 ml) MRAL 
IF 1 5.58 ± 0.036 3.61 ± 0.015 0.179 ± 0.007 3.46 : 1.90 
IF 2 5.68 ± 0.011 3.54 ± 0.021 0.162 ± 0.013 3.22 : 1.90 
IF 3 5.64 ± 0.011 3.59 ± 0.015 0.163 ± 0.002 3.06 : 1.75 
IF 4 5.65 ± 0.011 3.62 ± 0.020 0.171 ± 0.003 2.98 : 1.88 
IF 5 5.50 ± 0.026 3.47 ± 0.010 0.171 ± 0.003 3.10 : 1.94 
IF 6 5.65 ± 0.025 3.54 ± 0.015 0.186 ± 0.001 3.10 : 1.83 
BML 5.71 ± 0.030 3.75 ± 0.020 0.149 ± 0.006 3.12 : 1.95 
MBM 5.77 ± 0.017 3.49 ± 0.020 0.154 ± 0.001 3.11 : 1.80 
 
0 pH at the beggining of the experiment; 48 pH at the end of the investigation; IF, infant formula; 
BML, bifidobacteria medium with lactulose; MBM, mature breast milk; TOA, total organic 
acids; MRAL, mole ratio of acetic and lactic acid. 
 
 
 
mixture of feces collected from 30 babies. In addition, the 
mature breast milk substrate was a mixture of 20 breast 
milk samples obtained from 20 healthy mothers. 
Comparing the differences in the values of microbio-
logical and biochemical indicators of the bifidogenic 
effect, it can be seen that, the differences in the 
microbiological indicators were more distinct. For this 
reason, we proposed and used the BI. Using the BI 
calculation developed in the current study, the differences 
in the bifidogenic effect between individual infant 
formulas were clearly seen. With this in vitro investigation 
of infant formula, the bifidogenic effect can be easily 
monitored and objectively (all the conditions were 
controlled) determined and the quality of the infant formula 
evaluated in relation to this parameter. 
Since the concentration of the bacterially generated 
organic acids in all infant formulas was higher in relation 
to the reference and control substrate, this is very 
significant considering previous work in which it was 
stated that production of TOA with a lower pH may have 
an impact on the growth of other groups of bacteria, 
yeasts and fungi, since these are inhibited by weak acids 
in combination with a low pH (Adams and Hall, 1988; 
Moon, 1983; McWilliam Leitch and Stewart, 2002). 
Additionally, it has been reported that bifidobacteria and 
other lactic acid bacteria, secrete compounds bacteriocins, 
which directly influence the growth of other colonic 
bacteria, including pathogens (Gibson and Wang, 1994). 
Based on the results obtained during investigation of 
six commercial infant formulas, it can be concluded that 
the specimen IF-1 is the best one; the products, IF-2 to 
IF-4, have the same or similar bifidogenic effect and 
would belong to a medium category product, while the 
last two infant formulas would be in the lowest class. 
Since all the investigated products have similar declared 
nutritive and biological value, it is obvious that, their 
particular formulation plays a very important role, thus 
affecting their influence on growth of bifidobacteria or 
some contain substances which inhibit the activity of 
bifidobacteria. 
Based on all the in vitro obtained and discussed results, 
concerning this investigation developed for the estimation 
of the bifidogenic effect of infant formula in relation to 
mature breast milk as a reference substrate, the following 
conclusion can be made: The determined microbiological 
(description of the native microscopic preparation, total 
number of bifidobacteria and their dry biomass) and 
biochemical indicators (pH, bacterially generated total 
organic acids and the mole ratio of the obtained acetic 
and lactic acids) are suitable for tracking the in vitro 
bifidogenesis process. However, the dry biomass of 
bifidobacteria at the end of the investigation was the best 
indicator according to which it was possible to compare 
infant formulas in relation to the bifidogenic effect, as one 
of the most important parameters of their biological value 
and general quality. 
Despite the fact that the dry biomass is a distinct 
indicator of the bifidogenic effect of infant formula, it is 
necessary to monitor both the microbiological and bio-
chemical indicators in order to unambiguously establish 
whether the obtained changes in substrates are exclusively 
the consequence of bifidobacteria activity. 
The objectivity of the current investigation lies in the 
fact that, all the conditions during the experiment were 
controlled and the bifidogenic index, which is proposed 
here as a discriminatory criterion for the evaluation of the 
bifidogenic effect on the basis of the values obtained for 
six tested commercial infant formulas, clearly categorized 
the tested products.  
Further investigation should be directed to standardi-
zation of mature breast milk (in order to gain an average 
sample) and also to standardization of inoculum which 
would enable further evaluation of the BI test for 
measuring bifidogenic effect. Evolving an in vitro BI test 
would enable a reliable method for the examination of the 
biological value of infant formulas and it should produce 
quantitative discrimination in terms of food quality, which 
should be one of the most important factors in selection 
or development of infant formulas. 
In vitro tests have not been described in the literature 
yet, but clinical tests are performed since they are more 
reliable. However, they are also time-consuming, expen-
sive and connected to a series of problems, firstly with 
the number of babies on which  they  are  conducted  and  
  
 
 
 
their individual differences (Puccio et al., 2007; Ziegler et 
al., 2007).  
Further operations on the in vitro bifidogenic effect of 
infant formulas should be continued by investigating as 
many products which can be found on the market as 
possible, in order that they could also be discussed in 
relation to this property concerning the quality and utiliza-
tion of infant formulas and the obtained results compared 
with clinical (in vivo) tests.   
The final aim should be the standardization of the 
procedure for testing the bifidogenic effect and the 
introduction of this indicator into the criteria related to the 
scientific-based quality of infant formulas, that is, in a way 
that the bifidogenic effect is institutionalized. 
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